Vor Bio to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:

Piper Sandler 34th Annual Healthcare ConferencePresentation: Tuesday, November 29, 2022 at 9:30 am ETLocation: Lotte New York Palace Hotel, New York, NY

5th Annual Evercore ISI HealthCONx Virtual Conference Fireside chat: Thursday, December 1 at 3:05 pm ET

The JMP Securities Hematology and Oncology Virtual SummitFireside chat: Tuesday, December 6, 2022 at 1:20 pm ET

A live webcast and archived replay of the presentation and fireside chats will be available on the investors section of our website, linked here: https://ir.vorbio.com/events-presentations/

About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & InvestorsSarah Spencer +1 857-242-6076[email protected]

You May Also Be Interested In

• Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission
• Dryden Gold Clarifies Number of Claims on Lost Lake Property
• Brightspot Launches Esca Automations, Bringing Agentic Workflows to Content Operations